عنوان

Side-Effects of Anti-Inflammatory Drugs 3

(Number (ISBN

9401053251

(Number (ISBN

9401129827

(Number (ISBN

9789401053259

(Number (ISBN

9789401129824

Number

b595149

Title Proper

Side-Effects of Anti-Inflammatory Drugs 3

General Material Designation

[Book]

First Statement of Responsibility

edited by K.D. Rainsford, G.P. Velo.

Place of Publication, Distribution, etc.

Dordrecht

Name of Publisher, Distributor, etc.

Springer Netherlands : Imprint : Springer

Date of Publication, Distribution, etc.

1992

Specific Material Designation and Extent of Item

(400 pages)

Series Title

Inflammation and drug therapy series, 5.

Text of Note

Section I: Epidemiology --; 1 The gastrointestinal toxicity of the non-steroidal anti-inflammatory drugs --; 2 The value of the case-control approach for the evaluation of the risk of upper gastrointestinal bleeding associated with the previous use of non-steroidal anti-inflammatory drugs --; 3 Liver toxicity of antipyretic drugs in conjunction with measles infections --; 4 Non-steroidal anti-inflammatory drugs and hypersensitivity reactions --; 5 What can a spontaneous reporting system teach about side-effects of anti-inflammatory drugs? --; 6 Adverse reactions to NSAIDs: consecutive evaluation of 30 000 patients in rheumatology --; Section II: Gastrointestinal Tract: Clinical Aspects --; 7 The evaluation of acute gastrointestinal toxicity of NSAIDs in phase I clinical trials: a critical appraisal --; 8 The ulcerogenic and anti-haemostatic effects of NSAIDs in the gut --; 9 What role does Helicobacter pylori infection play in NSAID-associated gastric inflammation? --; 10 Endoscopic evaluation of NSAID ulceration --; 11 Food antigen absorption in rheumatoid arthritis: effect of acetylsalicylic acid --; 12 Intestinal mucosal permeability in inflammatory rheumatic diseases --; 13 Comparison of effects on gastrointestinal blood loss and gastric mucosal appearance of piroxicam-?-cyclodextrin, piroxicam and placebo --; Section III: Gastrointestinal Tract: Prevention Of Adverse Effects --; 14 Mechanisms of gastrointestinal ulceration from non-steroidal anti-inflammatory drugs: a basis for use and development of protective agents --; 15 Novel strategies of gastric and duodenal mucosal protection against NSAID injury: role of protease inhibitors, muscle relaxants and growth factors --; 16 The role of misoprostol in preventing NSAID-induced damage to the gastrointestinal tract --; 17 Possible factors involved in the protective effects of interleukin-1 in aspirin- and indomethacin-induced gastric damage --; 18 Prevention and treatment of NSAID-gastroduodenal damage: the role of H2-receptor antagonists --; 19 Omeprazole in the prevention and therapy of gastroduodenal lesions on NSAID therapy --; 20 Sucralfate in the prevention of NSAID-induced gastric ulceration --; 21 Ketotifen --; a novel approach to the prevention of damage in the gastrointestinal tract --; Section IV: Hepatotoxicity --; 22 The hepatotoxicity of non-steroidal anti-inflammatory drugs --; 23 Paracetamol (acetaminophen) bioactivation by liver microsomes --; its role in hepatotoxicity --; 24 Increased liver toxicity of diclofenac by paracetamol: results and possible mechanisms --; 25 Effects of NSAIDs on liver microsomal mono-oxygenase system and products of oxidative metabolism of arachidonic acid --; 26 Hepatitis due to non-steroidal anti-inflammatory drugs (NSAIDs) --; Section V: Nephrotoxicity --; 27 Current status of nephrotoxicity caused by non-steroidal anti-inflammatory drugs --; 28 Are oral prostaglandins effective in preventing nephrotoxicity from NSAIDs and cyclosporin? --; Section VI: Specific Issues Related To Side-Effects --; 29 Aspirin and Reye's syndrome --; 30 Antirheumatic drug therapy in the elderly --; 31 NSAIDs and human cartilage metabolism --; 32 Non-steroidal anti-inflammatory drugs and the augmented lipoxygenase pathway: conceivable impact on joint conditions --; 33 Therapeutic potential of 5-lipoxygenase inhibitors: the discovery and development of MK-886, a novelmechanism leukotriene inhibitor --; 34 Mechanisms of rash formation and related skin conditions induced by non-steroidal anti-inflammatory drugs --; Section VII: Antirheumatic And Immunoregulatory Agents --; 35 Cyclosporin: clinical efficacy and toxicity in patients with rheumatoid arthritis --; 36 Risk factors and risk-benefit problems in the use of DMARDs --; 37 Gold toxicity: chemical, structural, biological and clinical experimental issues --; Section VIII: Extended Poster Presentations --; 38 A review of interaction studies between non-steroidal anti-inflammatory drugs and HTreceptor antagonists or prostaglandin analogues --; 39 Influence of different anti-inflammatory substances on ethanol- and indomethacin-induced gastrointestinal mucosal damage --; 40 The role of copper in preventing gastric damage by acetylsalicylic acid --; 41 Effect of NSAID therapy on plasma, whole blood cell (BC), and 24h urine zinc in patients with rheumatoid arthritis (RA).

Text of Note

This book brings together physicians, scientists and those concerned with the production and use of anti-inflammatory drugs to discuss basic issues affecting all aspects of side-effects, including their detection and treatment.
The chapters cover a wide variety of topics including the epidemiology, clinical and experimental aspects of side-effects in the GI tract, liver, kidney, cartilage, bone and skin as well as the problems associated with the newer range of disease-modifying anti-rheumatic drugs such as methotrexate and cyclosporin.
This book will be of interest to all those who develop and use anti-inflammatory analgesic drugs, from basic scientists to clinicians. It contains papers presented at the Third International meeting on 'Side-Effects of Anti-Inflammatory and Analgesic Drugs' held in Verona, Italy, 8-11 May 1991.

Anti-inflammatory agents -- Side effects -- Congresses.

Anti-inflammatory agents -- Side effects.

edited by K.D. Rainsford, G.P. Velo.

G P Velo

K D Rainsford

Electronic name

[Book]

Y